BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2. Brewer RC, Ramadoss NS, Lahey LJ, Jahanbani S, et al. Nat Immunol 2021 Nov 30. pii: 10.1038/s41590-021-01088.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brewer RC, Ramadoss NS, Lahey LJ, Jahanbani S, et al. BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2. Nat Immunol 2021 Nov 30. pii: 10.1038/s41590-021-01088.
PMID: 34848871